Variant report
Variant | nsv611347 |
---|---|
Chromosome Location | chr8:51188675-51195151 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs552931141 | chr8:51192233-51192234 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs188885221 | chr8:51192251-51192252 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs148777773 | chr8:51192281-51192282 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs563920663 | chr8:51192288-51192289 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs575704756 | chr8:51192289-51192290 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs542370581 | chr8:51192430-51192431 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs555090969 | chr8:51192435-51192436 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs543205133 | chr8:51192469-51192470 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs561468474 | chr8:51192482-51192483 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs181683265 | chr8:51192504-51192505 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs187378422 | chr8:51192509-51192510 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs564847062 | chr8:51192512-51192513 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs532262516 | chr8:51192523-51192524 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs11987370 | chr8:51192524-51192525 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs568370237 | chr8:51192538-51192539 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs570054477 | chr8:51192552-51192553 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs142395166 | chr8:51192583-51192584 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs548356113 | chr8:51192695-51192696 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs566461722 | chr8:51192703-51192704 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs533811126 | chr8:51192709-51192710 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs552969785 | chr8:51192711-51192712 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs529930764 | chr8:51192742-51192743 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs577579162 | chr8:51192755-51192756 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs373318123 | chr8:51192761-51192762 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs557222843 | chr8:51192805-51192806 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs191980195 | chr8:51192844-51192845 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs542889740 | chr8:51192898-51192899 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs561511273 | chr8:51192908-51192909 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs180714820 | chr8:51192911-51192912 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs186019506 | chr8:51192931-51192932 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs564883585 | chr8:51192942-51192943 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs377369811 | chr8:51192946-51192947 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs532097457 | chr8:51192948-51192949 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs370758243 | chr8:51192959-51192960 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs562484304 | chr8:51193035-51193036 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs529780284 | chr8:51193095-51193096 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs78402521 | chr8:51193123-51193124 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs75926954 | chr8:51193144-51193145 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs533848772 | chr8:51193179-51193180 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs77136667 | chr8:51193193-51193194 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs570413227 | chr8:51193218-51193219 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs552177299 | chr8:51193275-51193276 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs562551904 | chr8:51193292-51193293 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs538699477 | chr8:51193329-51193330 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs557310828 | chr8:51193337-51193338 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs112065891 | chr8:51193338-51193339 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs531188210 | chr8:51193339-51193340 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs374957719 | chr8:51193440-51193441 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs535716560 | chr8:51193454-51193455 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs536722411 | chr8:51193484-51193485 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Melanoma | 17363583 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Glioma | 20126413 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Type 1 diabetes | 21085585 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:51192200-51192800 | Enhancers | Liver | Liver |
2 | chr8:51192200-51194200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
3 | chr8:51193600-51195000 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr8:51194200-51194400 | Active TSS | ES-UCSF4 Cell Line | embryonic stem cell |